GlassScriptPhysician profile
Hannah Slater
NPI 1073100624
$6,773.37
in general payments reported to CMS, 2019-2025
50 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,235 · 2022: $1,231 · 2023: $1,685 · 2024: $1,437 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,306.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,018.67 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $550.67 | 2021-2025 | Farxiga, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $490.55 | 2021-2024 | Shingrix, Arexvy |
| Pfizer INC. | $406.32 | 2021-2025 | |
| Amgen INC. | $370.14 | 2021-2025 | Repatha, Otezla, Repatha |
| Lundbeck LLC | $367.50 | 2022-2025 | Rexulti, Vyepti, Brintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $320.41 | 2021-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $297.90 | 2022-2025 | Glassia, Aralast, Trintellix |
| Lilly USA, LLC | $273.79 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Novo Nordisk INC | $262.75 | 2021-2025 | Wegovy |
| Otsuka America Pharmaceutical, INC. | $232.41 | 2021-2025 | Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $171.20 | 2023-2024 | Xarelto, Spravato |
| Kowa Pharmaceuticals America, INC. | $147.21 | 2022-2024 | Livalo, Seglentis, Zoryve |
| Esperion Therapeutics, INC. | $144.26 | 2022-2025 | Nexletol |
| Corcept Therapeutics | $138.20 | 2023 | Korlym |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $111.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $108.84 | 2023-2025 | Gemtesa |
| Axsome Therapeutics, INC. | $103.05 | 2025 | Symbravo, Auvelity |
| Medtronic, INC. | $94.27 | 2021-2025 | Minimed 780g, Minimed 770g |
| Heartflow, INC. | $83.10 | 2025 | |
| Astellas Pharma US INC | $80.71 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $76.32 | 2022 | |
| Aimmune Therapeutics, INC. | $70.79 | 2023-2024 | |
| Cranial Technologies, INC | $61.27 | 2022-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $54.69 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $48.54 | 2022-2023 | Ztlido |
| Bayer Healthcare Pharmaceuticals INC. | $46.02 | 2021-2023 | |
| Hologic Sales and Service, LLC | $44.85 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Boston Scientific Corporation | $43.86 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Amarin Pharma, INC. | $43.49 | 2021 | |
| Sanofi-Aventis U.S. LLC | $42.89 | 2021 | |
| Collegium Pharmaceutical, INC. | $42.06 | 2022-2023 | Belbuca |
| Novartis Pharmaceuticals Corporation | $40.23 | 2021 | |
| Corium, LLC | $38.92 | 2022-2023 | Azstarys |
| Bardy Diagnostics, INC. | $38.00 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $31.51 | 2023 | Quviviq |
| Vifor Pharma, INC. | $31.21 | 2025 | Zemaira |
| Edwards Lifesciences Corporation | $29.35 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ibsa Pharma INC. | $24.55 | 2025 | Tirosint, Flector, Licart |
| Sunovion Pharmaceuticals INC. | $21.54 | 2022 | |
| Antares Pharma, INC. | $21.30 | 2022 | |
| Abbott Laboratories | $20.78 | 2024 | Freestyle Libre 3 |
| Exeltis, USA INC. | $19.94 | 2023 | Slynd |
| Recordati_rare_diseases_inc. | $18.60 | 2024 | Isturisa, Signifor Lar |
| Shield Therapeutics INC | $18.37 | 2023 | Accrufer |
| Eisai INC. | $17.20 | 2021 | |
| Mylan Specialty L.P. | $15.80 | 2021 | |
| Acella Pharmaceuticals, LLC | $14.53 | 2023 | NP Thyroid 60 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.98 | 2022 | |
| Adlon Therapeutics L.P. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Slater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.